BioNTech SE: CEO Sahin Ugur sold 93,000 shares

What happened

• Sahin Ugur, CEO, sold a total of 93,000 ordinary shares: 72,000 shares on Oct 5, 2026 at $97.23 per share for $7,000,646, and 21,000 shares on Oct 6, 2026 at $96.81 per share for $2,032,995.

Key details

• Transaction dates and prices: Oct 5, 2026 at $97.23 (72,000 shares, $7,000,646); Oct 6, 2026 at $96.81 (21,000 shares, $2,032,995).
• Shares owned after the transactions: the filing does not state shares owned after these transactions.
• Footnote: the ordinary shares are held by Medine GmbH; the reporting person is the sole shareholder of Medine GmbH; 106,721 of the ordinary shares noted are held for the benefit of an individual under a trust arrangement where Medine GmbH exercises voting but not dispositive power; the reporting person may be deemed to beneficially own the ordinary shares held by Medine GmbH.
• Plan/remark: the sales were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on Jun 3, 2026.

Why it may matter

• The filing reports open-market sales executed under a 10b5-1 plan and shows holdings are held through an entity the reporting person controls.
• A filing does not show why the insider traded or why the company acted.